Cardiology Department III

Department of Cardiology III adheres in its medical practice to combining inheritance with innovation, taking the highlighting of the characteristics of traditional Chinese medicine and the improvement of medical quality and clinical efficacy as its core. It has an advanced level of medical care, a rigorous scientific approach, noble medical ethics and professional conduct, and keeps pace with developments in the cardiovascular field. It is at an advanced level in China and a leading level in Northwest China in interventional treatment of coronary heart disease (including interventional treatment of difficult and complex lesions such as left main coronary artery lesions, multivessel lesions, occlusive or calcified lesions, and bifurcation lesions), implantation of single-chamber, dual-chamber, and triple-chamber pacemakers and implantable cardioverter-defibrillators (ICD), radiofrequency ablation and cryoablation for paroxysmal supraventricular tachycardia, ventricular tachycardia, atrial tachycardia, atrial flutter, and atrial fibrillation, chemical ablation for hypertrophic obstructive cardiomyopathy, radiofrequency ablation or pacing therapy, balloon dilation valvuloplasty for mitral stenosis, and interventional closure of congenital heart disease. It has also achieved significant results in treating cardiovascular diseases including refractory hypertension, chronic refractory heart failure, coronary heart disease, acute myocardial infarction, rheumatic heart disease, cardiomyopathy, pericardial diseases, arrhythmias, infective endocarditis, and congenital heart disease. It continually summarizes the experience of renowned senior experts, conducts in-depth clinical research on cardiovascular diseases, and has standardized the integrated Chinese and Western medicine diagnosis, traditional Chinese medicine pattern differentiation, and characteristic treatment of the specialty's major diseases, including coronary heart disease, hypertension, arrhythmias, hyperlipidemia, and heart failure. Based on clinical pattern differentiation, the hospital's existing Chinese patent medicines, Tianxiangdan Granules, the Maitong Tablets series, and Qihong Granules, are used clinically as hospital preparations, with good results. It also provides characteristic diagnostic and treatment techniques such as acupoint application, acupuncture and moxibustion, and oral administration of traditional Chinese medicine decoctions; specialized treatments such as herbal wet-compress and pack therapy for coronary heart disease and chronic heart failure, thread-embedding therapy in the cardiovascular field, and external counterpulsation rehabilitation for patients with stable angina; and conducts research on comprehensive integrated Chinese and Western medicine rehabilitation for chronic heart failure and after coronary artery bypass grafting, as well as traditional Chinese medicine intervention for restenosis after coronary revascularization. Under the leadership of the department director, Parhat Tursun, it has developed into a comprehensive clinical department with a well-structured team, a high level of educational attainment, a core workforce mainly comprising young and middle-aged professionals, and strong technical and human resources. The specialty currently has 11 physicians, 2 supervisors of master's students, 2 chief physicians, 7 personnel with master's degrees, 1 postdoctoral fellow, 1 person with a doctoral degree, and 3 doctoral students currently enrolled. The department currently has 18 nursing staff. This specialty actively participates in scientific and technological innovation. Over the past five years, it has undertaken 11 research projects at the national, autonomous-region, and provincial/ministerial levels, with research funding of 940,000 yuan, including 1 National Natural Science Foundation project, 2 autonomous-region natural science foundation projects, 3 provincial/ministerial-level projects including key projects, 3 departmental/bureau-level projects, 1 multicenter collaborative project, and 1 university-level project of Xinjiang Medical University. Over the past five years, it has received autonomous-region science and technology progress awards, including 2 second-prize awards and 3 third-prize awards. It has published more than 90 scholarly works, including 44 articles in core journals and 8 indexed in SCI. It has served as a principal or contributing editor of 6 monographs and contributed to 1 textbook. This specialty ranks among the top in Xinjiang in terms of expert strength, research level, diagnostic and treatment technology, and informatization, and has consistently maintained a leading position in the diagnosis and treatment of cardiovascular diseases in Xinjiang using integrated Chinese and Western medicine. Department functions: Primarily provides interventional treatment for coronary heart disease, arrhythmias, and other conditions, and emergency rescue for all types of acute, critical, and severe cardiovascular conditions. Specialized services: It continually summarizes the experience of renowned senior experts, conducts in-depth clinical research on cardiovascular diseases, and has standardized the integrated Chinese and Western medicine diagnosis, traditional Chinese medicine pattern differentiation, and characteristic treatment of the specialty's major diseases, including coronary heart disease, hypertension, arrhythmias, hyperlipidemia, and heart failure. Based on clinical pattern differentiation, the hospital's existing Chinese patent medicines, Tianxiangdan Granules, the Maitong Tablets series, Qihong Granules, and Ningxin Tongbi Capsules, are used clinically as hospital preparations, with good results. It also provides characteristic diagnostic and treatment techniques such as acupoint application, acupuncture and moxibustion, and oral administration of traditional Chinese medicine decoctions; specialized treatments such as herbal wet-compress and pack therapy for coronary heart disease and chronic heart failure, thread-embedding therapy in the cardiovascular field, and external counterpulsation rehabilitation for patients with stable angina.